Literature DB >> 8089692

Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects.

J M Goldstein, S G Waxman, T L Vollmer, B Lang, I Johnston, J Newsom-Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8089692      PMCID： PMC1073150          DOI： 10.1136/jnnp.57.9.1138

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  11 in total

1.  Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.

Authors:  K Leys; B Lang; I Johnston; J Newsom-Davis
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

Review 2.  Multiple calcium channels and neuronal function.

Authors:  R J Miller
Journal:  Science       Date:  1987-01-02       Impact factor: 47.728

Review 3.  The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function.

Authors:  R R Llinás
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

4.  The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man.

Authors:  R W Cutler; G V Watters; J P Hammerstad
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

5.  Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome.

Authors:  J Newsom-Davis; N M Murray
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

6.  Autoantibodies bind solubilized calcium channel-omega-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome.

Authors:  V A Lennon; E H Lambert
Journal:  Mayo Clin Proc       Date:  1989-12       Impact factor: 7.616

7.  Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment.

Authors:  A M Blumenfeld; L D Recht; D A Chad; U DeGirolami; T Griffin; K A Jaeckle
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

8.  Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.

Authors:  B Lang; J Newsom-Davis; C Prior; D Wray
Journal:  J Physiol       Date:  1983-11       Impact factor: 5.182

Review 9.  Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome.

Authors:  P D Clouston; C B Saper; T Arbizu; I Johnston; B Lang; J Newsom-Davis; J B Posner
Journal:  Neurology       Date:  1992-10       Impact factor: 9.910

10.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

Authors:  J H O'Neill; N M Murray; J Newsom-Davis
Journal:  Brain       Date:  1988-06       Impact factor: 13.501
View more
  3 in total

1.  Paraneoplastic Diseases of the Nervous System.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-11       Impact factor: 3.598

2.  Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders.

Authors:  Josep Dalmau; Luis Bataller
Journal:  Hematol Oncol Clin North Am       Date:  2006-12       Impact factor: 3.722

3.  Voltage-gated calcium channel autoimmune cerebellar degeneration: Case and study of cytotoxicity.

Authors:  Marilyn McKasson; Stacey L Clardy; Susan A Clawson; Kenneth E Hill; Blair Wood; Noel Carlson; Mark Bromberg; John E Greenlee
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.